Related Experiment Video

Updated: Jun 28, 2026

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures
10:01

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

[How to evaluate sudden cardiac death risk after myocardial infarction?]

E Marijon1, S Boveda, N Combes

  • 1Département de rythmologie, clinique Pasteur, 43-45, avenue de Lombez, BP 27617, 31076 Toulouse cedex 3, France. eloi marijon@yahoo.fr

Annales De Cardiologie Et D'Angeiologie
|October 22, 2008
PubMed

Insights

Sudden cardiac death prevention requires assessing heart disease, risk factors, and treatments. New markers like heart rate variability may improve risk prediction after heart attack.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Preventive Medicine

Context:

  • Sudden cardiac death (SCD) accounts for over half of deaths in coronary heart disease (CHD) patients.
  • Preventing SCD involves managing ventricular arrhythmias and considering implantable cardioverter-defibrillators (ICDs).
  • Risk evaluation for SCD necessitates understanding cardiopathy, coronary risk factors, and treatments mitigating ventricular remodeling and ischemia.

Purpose:

  • To review current strategies for SCD prevention and risk stratification.
  • To highlight limitations in current French guidelines for ICD implantation in primary prevention.
  • To explore the potential of novel noninvasive markers for SCD risk assessment.

Summary:

  • Current French guidelines for ICD implantation in primary prevention primarily consider low ejection fraction and positive ventricular testing.
  • Pharmacological treatments aimed at reducing ventricular remodeling and myocardial ischemia are crucial in SCD prevention.
  • Noninvasive markers like heart rate variability and T wave alternans show promise for SCD risk stratification post-myocardial infarction.

Impact:

  • This review emphasizes the need for comprehensive SCD risk assessment beyond current guidelines.
  • It highlights the potential of emerging noninvasive markers to refine patient selection for interventions.
  • The findings could inform updated clinical recommendations for SCD prevention and management.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...